@inproceedings{c02fcd522aa84d47868e522648b6d27f,
title = "670nm - A stop sign for retinal degenerations?",
abstract = "This article presents a review of the work conducted in our laboratories using the 670nm light to test its efficacy in preventing or slowing the progression of retinal degeneration in the rodent retinal light-damage model. Using this model as an archetype of dry age-related macular degeneration we propose that 670nm light could be a viable option in the treatment of human AMD. We have found that irradiation of the eye with the 670nm light, using LED light arrays showed beneficial effects in photoreceptor survival1, 2, vascular development3 and moderating glial activation4 in a variety of rodent models. Based on these findings, we believe that photobiomodulation with 670nm red light has a great potential in retinal therapeutics, providing a non-invasive, and cost-effective treatment in retinal injury and degenerative conditions.",
author = "K. Valter and R. Albarracin and R. Natoli and M. Rutar and J. Provis",
note = "Publisher Copyright: {\textcopyright} Medimond.; 2014 WALT Biennial Congress and NAALT Annual Conference ; Conference date: 09-09-2014 Through 12-09-2014",
year = "2014",
language = "English",
series = "Proceedings of the WALT Biennial Congress and NAALT Annual Conference",
publisher = "MEDIMOND s.r.l.",
pages = "33--38",
editor = "E.-Liisa Laakso",
booktitle = "Proceedings of the WALT Biennial Congress and NAALT Annual Conference",
}